Lido Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Lido Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$295K	Sell	600 -1,100	-65%	-$597K	﹤0.01%	1575
2025 Q4	$985K	Hold	1,700	–	–	﹤0.01%	1011
2025 Q3	$825K	Hold	1,700	–	–	﹤0.01%	1036
2025 Q2	$689K	Buy	1,700 +1,300	+325%	+$544K	﹤0.01%	989
2025 Q1	$199K	Sell	400 -400	-50%	-$217K	﹤0.01%	1393
2024 Q4	$416K	Sell	800 -200	-20%	-$110K	﹤0.01%	1073
2024 Q3	$619K	Buy	1,000 +400	+67%	+$237K	﹤0.01%	879
2024 Q2	$332K	Buy	600 +400	+200%	+$229K	﹤0.01%	1070
2024 Q1	$116K	Sell	200 -400	-67%	-$224K	﹤0.01%	1313
2023 Q4	$318K	Sell	600 -200	-25%	-$96.8K	﹤0.01%	1010
2023 Q3	$405K	Buy	800 +200	+33%	+$107K	﹤0.01%	805
2023 Q2	$313K	Hold	600	–	–	﹤0.01%	910
2023 Q1	$346K	Hold	600	–	–	﹤0.01%	829
2022 Q4	$330K	Buy	+600	New	+$318K	﹤0.01%	763
2019 Q4	–	Sell	-1,300	Closed	-$378K	–	684
2019 Q3	$378K	Hold	1,300	–	–	0.02%	401
2019 Q2	$381K	Hold	1,300	–	–	0.02%	366
2019 Q1	$355K	Buy	+1,300	New	+$324K	0.02%	354

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lido Advisors's TMO Position: Q1 2026 in Review

Lido Advisors reduced its Thermo Fisher Scientific (TMO) stake by 9.3% in Q1 2026, selling an estimated $2.23M and leaving 39,978 shares worth $19.7M. The position accounts for 0.06% of the portfolio, ranked #206.

Lido Advisors first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $22.9M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Lido Advisors held 39,978 shares of Thermo Fisher Scientific worth $19.7M as of Q1 2026.
Lido Advisors sold 4,116 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.23M.
Thermo Fisher Scientific made up 0.06% of Lido Advisors's portfolio in Q1 2026, its #206 holding.
Lido Advisors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
Lido Advisors's Thermo Fisher Scientific position peaked at $22.9M in Q4 2025.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.